Ziltivekimab is under clinical development by Novo Nordisk and currently in Phase III for Myocardial Infarction.

Nelonemdaz (Neu2000) is under development for the treatment of acute ischemic stroke, traumatic brain injury, traumatic spinal cord injury and burn injury, cerebral infarction. It is administered ...

Three people have reportedly died due to noncommunicable diseases (NCDs), including stroke, acute coronary syndrome, and ...

Labor and militant groups have denounced President Marcos’ failure to restore the scrapped subsidy for Philippine Health ...

Srinagar: A Central Reserve Police Force (CRPF) head constable died in mysterious circumstances in Jammu and Kashmir’s ...

Doctors in Kashmir warn of heightened heart attack and stroke risks amid sub-zero temperatures. Cold weather causes ...

The Department of Health (DOH) on Monday, Dec. 30 urged the public to exercise caution as the holiday season continues, ...

INR:1356. saudi pro league 23-24 schedule Roche withdraws US marketing approval for Tecentriq as second-line treatment for ...

Clinical Electrophysiology journal showed that when acute procedural success is attained in a subset of patients with ...

disawar satta king mein kya khula "Pharmaceutical Speed Reading Club" Novartis CD20 monoclonal antibody is planned to be ...